Pictet Asset Management (Switzerland)’s Pacira BioSciences PCRX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio PCRX Stock Details PCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$203K	Buy
2022 Q2	–	Sell
2022 Q1	$5.15M	Sell
2021 Q4	$4.1M	Sell
2021 Q3	$4.26M	Buy